IT8422954A0 - Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua. - Google Patents

Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua.

Info

Publication number
IT8422954A0
IT8422954A0 IT8422954A IT2295484A IT8422954A0 IT 8422954 A0 IT8422954 A0 IT 8422954A0 IT 8422954 A IT8422954 A IT 8422954A IT 2295484 A IT2295484 A IT 2295484A IT 8422954 A0 IT8422954 A0 IT 8422954A0
Authority
IT
Italy
Prior art keywords
formulation
procedure
water
controlled release
soluble components
Prior art date
Application number
IT8422954A
Other languages
English (en)
Other versions
IT1176853B (it
IT8422954A1 (it
Inventor
Leonardo Gentilini
Massimo Calanchi
Original Assignee
Eurand Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Spa filed Critical Eurand Spa
Priority to IT22954/84A priority Critical patent/IT1176853B/it
Publication of IT8422954A0 publication Critical patent/IT8422954A0/it
Priority to EP85112360A priority patent/EP0177000A1/en
Publication of IT8422954A1 publication Critical patent/IT8422954A1/it
Application granted granted Critical
Publication of IT1176853B publication Critical patent/IT1176853B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
IT22954/84A 1984-10-02 1984-10-02 Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua IT1176853B (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT22954/84A IT1176853B (it) 1984-10-02 1984-10-02 Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua
EP85112360A EP0177000A1 (en) 1984-10-02 1985-09-30 Process to obtain a sustained release formulation of water soluble components

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22954/84A IT1176853B (it) 1984-10-02 1984-10-02 Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua

Publications (3)

Publication Number Publication Date
IT8422954A0 true IT8422954A0 (it) 1984-10-02
IT8422954A1 IT8422954A1 (it) 1986-04-02
IT1176853B IT1176853B (it) 1987-08-18

Family

ID=11202258

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22954/84A IT1176853B (it) 1984-10-02 1984-10-02 Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua

Country Status (2)

Country Link
EP (1) EP0177000A1 (it)
IT (1) IT1176853B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
ES2022454B3 (es) * 1986-06-17 1991-12-01 Recordati Ind Chimica E Farm S P A Sistema terapeutico para la liberacion controlada de drogas.
EP0951278A2 (en) * 1997-01-03 1999-10-27 ELAN CORPORATION, Plc Sustained release cisapride mini-tablet formulation
US7387793B2 (en) 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
KR101597004B1 (ko) * 2013-07-25 2016-02-23 씨제이헬스케어 주식회사 서방형 메트포르민과 속방형 HMG-CoA 환원효소 억제제를 포함하는 복합제제

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB931148A (it) * 1900-01-01
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3362880A (en) * 1963-09-20 1968-01-09 Dow Chemical Co Compressed drug tablets of ethyl cellulose, glyceryl monostearate, karaya gum, tragacanth, talc, and magnesium stearate
US3400185A (en) * 1965-04-08 1968-09-03 Bristol Myers Co Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
FR2492661A1 (fr) * 1980-10-28 1982-04-30 Laruelle Claude Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル

Also Published As

Publication number Publication date
IT1176853B (it) 1987-08-18
IT8422954A1 (it) 1986-04-02
EP0177000A1 (en) 1986-04-09

Similar Documents

Publication Publication Date Title
FI871314A7 (fi) Pinta-aktiivista ainetta sisältävät lääkeaineadsorbaatit ja menetelmä niiden valmistamiseksi.
FI894888A7 (fi) Astaksantiinia tuottavia hiivasoluja, menetelmiä niiden valmistamiseks i ja niiden käyttö
IT1149274B (it) Cementi solubili in acidi e metodi per impiegarli
DK443287D0 (da) Substituerede benzoylphenlurinstoffer samt deres fremstilling og anvendelse
FI870582A7 (fi) Aminouretaaneja, niiden valmistusmenetelmä ja niiden käyttö
FI874398A7 (fi) Makeisvalmiste ja menetelmä sen valmistamiseksi.
FI822132A7 (fi) Optisesti aktiiviset 1-aromaattisella ryhmällä substituoitu-1-alkanolit ja niiden valmistusmenetelmä.
FI885592A7 (fi) Aryloksifenyylipropyyliamiinit, niiden valmistus ja käyttö
IT1127248B (it) Preparazioni gonadotropiniche corioniche e metodi per impiegarle
FI884268A7 (fi) Suprajohtavat aineet ja niiden valmistusmenetelmä.
ES544991A0 (es) Un metodo para producir una composicion de gamma-interferon de ser humano.
FI880849A7 (fi) Uudet siloksaani-bis-maleimidit ja niiden valmistusmenetelmä.
IT8422954A0 (it) Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua.
DK385185D0 (da) Substituerede phenylurinstoffer, deres fremstilling og anvendelse
FI881097A0 (fi) Sorafeeni, menetelmä sen valmistamiseksi ja sen käyttö kasvitautien torjumiseksi
IT8324203A0 (it) Procedimento per la preparazione di dioli vicinali solubili in acqua.
IS1422B6 (is) Lína til línuveiða
IT7829704A0 (it) Impiego di una composizione tixotropica,metodo di preparazionedi detta composizione e procedimento per ottenere il compinente attivo
EP0321428A3 (en) Use of glycerol ethers in dermatological diseases
IT1215950B (it) Metodo per formare una sagoma.
DK586985D0 (da) 2-pyridylthionophoshorsyreestere, deres fremstilling og anvendelse
IT1158423B (it) Coloranti disazoici solubili in acqua, loro preparazione e loro impiego
ATA87988A (de) Pflugnachlaeufer
ATA78088A (de) Pflugnachlaeufer
DK252879A (da) (1-alkyl-5-nitro-2-imidazolyl)-vinylglyoxaldiacetaler deres fremstilling og deres anvendelse